Stock Events

Stock Events

Vanda Pharmaceuticals (VNDA) Q2 2026 Earnings

May 6Confirmed

Q3 2025

Q4 2025

Q1 2026

Q2 2026

-2.39

-1.71

-1.03

-0.36

Details

Expected EPS

-0.688

Actual EPS

-0.82

Surprise EPS

-0.13

Surprise Percent

-19.19%

Description

⁨Vanda Pharmaceuticals⁩ (⁦VNDA⁩) has reported earnings of ⁦-0.82⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.